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Abstract
Background: Despite the well-documented association between loss of E-cadherin and carcinogenesis, as well as the link
between restoration of its expression and suppression of proliferation in carcinoma cells, the ability of E-cadherin to
modulate growth-promoting cell signalling in normal epithelial cells is less well understood and frequently contradictory.
The potential for E-cadherin to co-ordinate different proliferation-associated signalling pathways has yet to be fully
explored.
Methodology/Principal Findings: Using a normal human urothelial (NHU) cell culture system and following a calcium-
switch approach, we demonstrate that the stability of NHU cell-cell contacts differentially regulates the Epidermal Growth
Factor Receptor (EGFR)/Extracellular Signal-Regulated Kinase (ERK) and Phosphatidylinositol 3-Kinase (PI3-K)/AKT pathways.
We show that stable cell contacts down-modulate the EGFR/ERK pathway, whilst inducing PI3-K/AKT activity, which
transiently enhances cell growth at low density. Functional inactivation of E-cadherin interferes with the capacity of NHU
cells to form stable calcium-mediated contacts, attenuates E-cadherin-mediated PI3-K/AKT induction and enhances NHU cell
proliferation by allowing de-repression of the EGFR/ERK pathway and constitutive activation of b-catenin-TCF signalling.
Conclusions/Significance: Our findings provide evidence that E-cadherin can differentially and concurrently regulate
specific growth-related signalling pathways in a context-specific fashion, with direct, functional consequences for cell
proliferation and population growth. Our observations not only reveal a novel, complex role for E-cadherin in normal
epithelial cell homeostasis and tissue regeneration, but also provide the basis for a more complete understanding of the
consequences of E-cadherin loss on malignant transformation.
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Introduction
E-cadherin is a member of the cadherin family of transmem-
brane glycoproteins that mediates formation of adherens junctions
in epithelial cells [1]. Formation of calcium-dependent ‘‘zipper-
like’’ homophilic interactions between the extracellular domains of
E-cadherin on adjacent cells facilitates epithelial cell-cell contact
and adhesion [2]. These interactions are stabilised by the
association of the cytoplasmic tail of E-cadherin with the a, b
and c catenins, which anchor E-cadherin to the cytoskeleton [3].
In epithelial tissues, E-cadherin functions not only to stabilise
homotypic cell interactions, but also to modulate extracellular
growth-associated signals, thus providing a homeostatic mecha-
nism to link cell-cell contact/adhesion with cellular proliferation
and tissue growth. For instance, E-cadherin interacts with b-
catenin, a multifunctional protein that regulates cell growth by
acting as a transcription factor in Wnt signalling [4]. The
association between E-cadherin and b-catenin not only stabilises
the adherens complex itself, but also provides a mechanism by
which E-cadherin can sequester b-catenin to the cell membrane
and impede b- catenin/TCF-mediated transcription [5,6]. Al-
though the cytoplasmic tail of E-cadherin lacks enzymatic activity,
it can regulate growth-promoting cell signalling, such as the
Phosphatidylinositol 3-Kinase (PI3-K)/AKT and Extracellular
Signal-Regulated Kinase (ERK) pathways, by influencing the
activation of receptor tyrosine kinases (RTKs). Some studies have
reported positive regulation of Epidermal Growth Factor Receptor
(EGFR) downstream signalling through ERK [7,8] and PI3-K/
AKT [9] following calcium-mediated formation of E-cadherin
intercellular contacts in monocultures of normal keratinocytes and
cancer cell lines, respectively. Yet, using the same calcium-switch
approach, others have demonstrated that E-cadherin-mediated
cell-cell adhesion can inhibit the ligand-dependent activation of
diverse RTKs, including EGFR [10,11]. Although these studies
imply a critical, context-specific role for E-cadherin-dependent
cell-cell contacts in modulating growth-promoting intracellular
signalling pathways, many of the described findings are contra-
dictory. Equally importantly, it remains unknown whether E-
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cadherin can simultaneously regulate these pathways and/or how
the influence of E-cadherin on these signalling cues dictates
epithelial cell behaviour, particularly within the tissue context.
We have previously developed a culture system for normal
human urothelial (NHU) cells [12]. In low calcium (0.09 mM),
serum-free culture medium, NHU cells adopt a highly prolifera-
tive, regenerative phenotype which is driven via the ERK,
mitogen-activated protein kinase (MAPK) cascade downstream
of an EGFR-activated autocrine pathway, with amphiregulin and
HB-EGF identified as the key endogenous ligands [13]. A switch
to physiological (2 mM) calcium induces stratification and the
formation of adherens and tight junctional complexes, but does
not induce urothelial cytodifferentiation [14], although the cells
retain the capacity to differentiate [15] and to form a functional
barrier epithelium [16].
To aid interpretation of the cellular basis of tissue regulatory
mechanisms, we have previously developed the ‘‘Epitheliome’’, an
agent-based computational model of epithelial cell behaviour
[17,18,19]. By incorporating rule sets to describe concepts of
calcium-dependent bonding and a G1 checkpoint operated by
contact inhibition, we have shown good qualitative agreement
between in virtuo simulations and experimentally-acquired growth
kinetics for NHU cell cultures. In low (0.09 mM) exogenous
calcium concentrations, both real and simulated cell cultures
display higher growth rates and achieved greater final cell densities
than equivalent cultures grown in physiological (2 mM) calcium,
where the tendency towards colony formation results in early exit
from cell cycle due to contact inhibition [17]. The single
discrepancy was that low-density NHU cell cultures in 2 mM
calcium conditions consistently showed a higher growth rate
compared to cultures in 0.09 mM calcium, which was not
replicated in the simulated system [17]. This has been examined
computationally by exploring growth signals augmented through
E-cadherin-dependent cell-cell contacts [20]. These observations
predict a more complex interplay between signalling mechanisms
for the regulation of cellular growth at different population
densities.
The aim of our present study was to identify the growth-
promoting pathways that underpin the above observations and
contribute to the regulation of epithelial tissue homeostasis and
regeneration. The urothelium, which is able to switch from a
mitotically quiescent to a highly-proliferative regenerative tissue in
response to damage, represents an ideal model system. Using a
functional inactivation approach, we demonstrate that E-cadherin
interactions simultaneously regulate multiple growth-promoting
signalling pathways and that the pattern of activation of these
pathways accounts for the cell-growth differences observed. Our
findings not only reveal a complex role for E-cadherin in
regulating growth signals in normal epithelial cells, but also
provide further insight into the functional consequences of E-
cadherin loss in neoplastic disease.
Results
The stability of NHU cell-cell contacts differentially
regulates the EGFR/ERK and PI3-K/AKT signalling
pathways
Growth curves were constructed from cell counts of NHU cell
cultures maintained in low (0.09 mM) and near physiological
(2 mM) calcium concentrations. In all cases, cultures were
maintained in the presence of saturating concentrations of
exogenous EGF in order to limit any confounding effects from
autocrine/juxtacrine EGFR activation [13]. NHU cell cultures
maintained in 2 mM calcium exhibited higher growth rates during
exponential growth phase than cultures grown in 0.09 mM
calcium conditions. By contrast, cultures maintained in 0.09 mM
calcium grew more slowly, but attained a higher ultimate cell
density (Figure 1A).
As EGFR/ERK signalling is critical in NHU cell proliferation
[13], we used immunofluorescence microscopy to examine the
expression of EGFR and its downstream signalling effector, ERK,
24 hours following a switch from 0.09 mM to 2 mM calcium. The
calcium switch resulted in a major down-regulation of nuclear
phospho-ERK, despite the total amount of ERK remaining
unchanged (Figure 1B). Along with an increase in the overall
expression level of EGFR, we observed a change in localisation
from diffuse cytoplasmic to intense, punctate labelling in
cytoplasmic and perinuclear areas (Figure 1B). Immunoblotting
studies, carried out to monitor EGFR and phospho-ERK over a
24-hour time-course, confirmed the increase in EGFR expression,
which occurred within 12 hours of treatment, as well as the
decrease in phospho-ERK as early as 3 hours following the
calcium-switch (Figure 1C).
The reduction in phospho-ERK activity indicated that
formation of calcium-mediated, ‘stable’ intercellular contacts did
not result in increased EGFR/ERK signalling and suggested that
this pathway is unlikely to be responsible for the increased
proliferation rate in low-density cultures. As activation of the PI3-
K/AKT pathway has been previously implicated in cell contact-
dependent proliferation [9,21], the possibility of an induction of
AKT activity was investigated. Immunoblotting studies revealed
the emergence of phosphorylated AKT on Ser-473, which
occurred within 12 hours of switching to 2 mM calcium
(Figure 2A); by contrast no phospho-AKT on Tyr-308 was
observed (not shown). The findings were confirmed by immuno-
fluorescence microscopy, which showed phospho-AKT to be
nucleus-localised (Figure 2B). Only cells making direct contacts
with neighbouring cells showed intense activation of AKT, whilst
lone cells showed little, if any, detectable phospho-AKT (Figure 2B,
right top panel, denoted by arrows). This implied that it was the
formation of cell-cell contacts, rather than addition of calcium
alone, which was critical for AKT activation. To corroborate
direct functional involvement of the PI3-K/AKT pathway in the
enhancement of growth rates, population growth was assessed for
NHU cell cultures grown in 0.09 mM or 2 mM calcium in the
presence or absence of the specific PI3-K inhibitor LY294002 over
a 7 day time-course (Figure 2C). In confirmation of the kinetic
data shown above (Figure 1A), NHU cells grown in 2 mM calcium
showed higher proliferation rates during exponential growth,
whereas cultures grown in 0.09 mM calcium achieved a higher
density by day 7. The increased proliferation rate, characteristic of
cultures grown in 2 mM calcium, was completely abolished by
LY294002 treatment, whereas LY294002 had little effect on the
exponential growth rate of cultures grown in low calcium medium
(Figure 2C). These results indicate that stable, calcium-mediated,
cell-cell interactions enhanced proliferation by activation of the
PI3-K/AKT pathway in sub-confluent cultures. By contrast, the
enhanced cell-cell contacts produced in physiological calcium
conditions appeared to promote earlier exit from the cell cycle (as
indicated by the lower growth rates at later time points),
presumably due to cell contact inhibition.
Expression of a dominant-negative E-cadherin mutant
interferes with expression and localisation of
endogenous E-cadherin and catenins
To examine further the importance of cell-cell contacts in
regulating proliferation, the effect of modifying adherens junctions
was examined. Due to the critical role of E-cadherin in the
E-Cadherin Growth Regulation
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Figure 1. Physiological calcium causes a transient increase in proliferation in low density NHU cultures which is independent of
EGFR/ERK signaling. (A) NHU cells were seeded in 6-well plates at 26104/well in medium containing 0.09 mM (Low Ca2+) or 2.0 mM (Phys Ca2+)
extracellular [Ca2+]. Cell growth was determined by cell counting for a total period of 9 days. Each data point represents the mean (6S.E.M.) of 3
replicates (n = 3) and results are representative of at least three independent experiments. ns, non-significant; *, P,0.05; **, P,0.01. (B) NHU cells
were cultured as above and expression of EGFR, phospho-ERK (pERK) and total ERK was assessed by immunofluorescence microscopy using rabbit
(EGFR and p-ERK) and mouse (total ERK) antibodies, followed by goat antisera conjugated with Alexa Fluor 488 (green) or 594 (red). Cell nuclei were
visualised using Hoechst 33258 (blue). (C) NHU cells were seeded in standard culture medium (0.09 mM calcium) and left to attach overnight. Calcium
concentration was then increased to 2 mM and protein lysates were prepared at the indicated time-points for gel-electrophoresis and
immunoblotting. Expression of EGFR, phospho-ERK (pERK), total ERK and b-actin was determined using mouse antibodies (total ERK/b-actin) and
rabbit antisera (EGFR/pERK), followed by goat anti-mouse antibody conjugated with Alexa Fluor 680 (red) or goat anti-rabbit antibody conjugated
with IRDye 800 (green). Densitometry was performed to determine fold induction of EGFR and pERK expression following normalisation against b-
actin and total ERK, respectively. Bar graphs represent results relative to the expression level of the initial time point (0 hours).
doi:10.1371/journal.pone.0013621.g001
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formation of cell-cell contacts and its potential involvement in the
regulation of such signalling pathways, we performed functional
inactivation of E-cadherin in NHU cells by transduction with a
retrovirus expressing the dominant-negative E-cadherin construct
H-2Kd-E-cad [22,23]. The construct encodes a chimeric protein
comprising the extracellular domain of H-2Kd class I and the
transmembrane and intracellular domains of E-cadherin. Recom-
binant retrovirus expressing the E-cadherin mutant was used to
infect NHU cells alongside a control virus, giving rise to isogenic
sub-lines NHU-ECmut and NHU-Con, respectively. As our
optimised retrovirus method for stable NHU cell transduction is
.90% efficient [24], NHU sub-lines were derived as non-clonal
populations, thus negating integration artefacts. By flow cytometry
detection, the expression of surface H-2Kd-E-cad on NHU-
ECmut cells was very low (Figure 3A, upper panels), but
immunofluorescence microscopy showed substantial intracellular
expression, with the H-2Kd-E-cad protein localising mainly to
perinuclear areas (Figure 3A, lower panels).
In low calcium medium, NHU cells showed moderate, diffuse
cytoplasmic E-cadherin expression, which became intense and
localised to intercellular borders within hours of switching to
physiological calcium (Figure 3B). Associated with the calcium-
mediated stabilisation of E-cadherin, the major cytoplasmic-
domain partners of E-cadherin were also relocated to different
intracellular compartments. Thus, a-catenin showed a change
from diffuse cytoplasmic to intense plasma membrane and
cytoskeletal filament localisation, whereas b-catenin relocalised
from the nucleus to cell-cell contact points (Figure 3B). Expression
of the dominant-negative E-cadherin construct H-2Kd-E-cad
caused a dramatic change in the pattern of endogenous E-
cadherin localisation. In the retrovirus-transduced NHU-ECmut
cells maintained in 2 mM calcium, E-cadherin was detected in
Figure 2. Calcium-induced increase in proliferation in low-density NHU cultures occurs via activation of the PI3-K/AKT pathway. (A)
NHU cells were seeded in medium containing low [Ca2+] (0.09 mM) and left to attach overnight. Calcium concentration was then increased to 2 mM
and protein lysates were prepared at the indicated time-points for immunoblotting. Expression of phospho-AKT (green) and total AKT (red) was
determined using rabbit and mouse antibodies, respectively, followed by fluorochrome-conjugated secondary antisera as in Figure 1C.
Immunolabelling was visualised and densitometry to determine fold induction of p-AKT expression with respect to total AKT was performed as in
Figure 1C. (B) NHU cells were cultured in medium containing 0.09 mM (Low Ca2+) or 2.0 mM (Phys Ca2+) [Ca2+]. Expression of phospho-AKT (p-AKT)
was determined by immunofluorescence microscopy using anti-p-AKT rabbit antibody followed by goat anti-rabbit antibody conjugated with Alexa
Fluor 488 (green). Cell nuclei were visualised using Hoechst 33258 (blue). (C) NHU cells were seeded into 96-well plates and cultured for a period of 7
days in medium containing either low (-Ca) or physiological (+Ca) calcium levels, in the presence or absence of 5 mM of the PI3-K inhibitor LY294002.
Proliferation was determined on the basis of cell biomass using the MTT assay. Data points represent mean absorbance values for 6 replicate wells
(6S.E.M.). Results for all data points are also presented in the form of bar graphs (lower panel) for the purpose of statistical analysis. ns, non-
significant; **, P,0.01; ***, P,0.001.
doi:10.1371/journal.pone.0013621.g002
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Figure 3. Effect of dominant-negative mutant E-cadherin on expression and localisation of endogenous E-cadherin and catenins in
NHU cells. (A) NHU cells expressing the H-2Kd-E-cad mutant (NHU-ECmut) and their isogenic controls (NHU-Con) were established by retrovirus
transduction and expression of mutant E-cadherin was assessed by flow cytometry and immunofluorescence microscopy. For flow cytometry (upper
panels), expression was analysed using FITC-conjugated anti-H-2Kd antibody (open histograms) alongside irrelevant isotype-matched control
antibody (filled histograms). Histograms represent log10 fluorescence intensity in the FL-1 channel. For immunofluorescence microscopy (lower
panels), expression was detected using anti-H-2Kd antibody followed by goat anti-mouse antibody conjugated with Alexa Fluor 488 (green). (B)
Following initial seeding, NHU cells were cultured in medium containing low (0.09 mM) or physiological (2.0 mM) Ca2+ concentrations for 24 hours
before expression of E-cadherin, a-catenin and b-catenin was assessed by microscopy using mouse (E-cadherin) and rabbit (catenins) antibodies,
followed by goat antisera conjugated with Alexa Fluor 488 (green) or 594 (red). (C) NHU-Con and NHU-ECmut cells were cultured in medium
containing physiological [Ca2+] and expression of E-cadherin, a-catenin and b-catenin was determined by labelling using primary antibodies above,
followed by Alexa Fluor 488-conjugated antibody (green). In all immunofluorescence microscopy experiments, cell nuclei were visualised by labelling
with Hoechst 33258 (blue).
doi:10.1371/journal.pone.0013621.g003
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perinuclear, Golgi/late-endosome compartments (compare left
and right panels, Figure 3C), synonymous with the perinuclear
localisation of the H-2Kd-E-cad chimera (lower panels, Figure 3A).
Associated with the loss of surface E-cadherin in NHU-ECmut
cells, there was down-regulation of a-catenin and increased
expression of nuclear b-catenin (Figure 3C). These experiments
confirmed that the H-2Kd-E-cad mutant expressed in NHU cells
was functional, as it efficiently incapacitated endogenous E-
cadherin by blocking localisation to sites of cell-cell contact and
preventing recruitment of a- and b-catenin.
Functional inactivation of E-cadherin enhances NHU cell
proliferation and reveals a pattern of E-cadherin-
mediated differential regulation of EGFR/ERK, PI3-K/AKT
and b-catenin/TCF signalling
Following retrovirus transduction and antibiotic selection,
NHU-ECmut cells exhibited a consistently higher proliferation
rate than the isogenic controls. This was noticeable during routine
maintenance of the cultures and was confirmed quantitatively by
[3H]-thymidine incorporation assays. These experiments showed
that NHU-ECmut cells displayed consistently higher proliferation
rates than NHU-Con cells in both low and physiological calcium
conditions (Figure 4A). Population growth curves were also
constructed over a period of 9 days. NHU-Con showed similar
growth characteristics to non-transduced NHU cells, with a higher
growth rate at lower density when cultured in physiological
calcium (Figure 4B). In comparison to the control cells, the growth
rate of NHU-ECmut was elevated in low calcium conditions and
NHU-ECmut cells maintained in physiological calcium showed
virtually identical growth rates to NHU-Con cells cultured in low
calcium (Figure 4B); this was in agreement with the results from
[3H]-thymidine incorporation assays (Figure 4A). Therefore,
expression of mutant E-cadherin effectively overcame the
inhibition of growth seen in 2 mM calcium in NHU and NHU-
Con cell cultures.
We then examined the effect of abrogation of E-cadherin
function on the activity of the EGFR/ERK and PI3-K/AKT
pathways. The addition of physiological calcium to NHU-Con cell
cultures resulted in reduced phospho-ERK levels by almost 3-fold
(Figure 4C) as expected. By contrast, in NHU-ECmut cells there
was little (if any) reduction in ERK phosphorylation observed
(Figure 4C). At the same time, despite a substantial increase in
phosphor-AKT (on Ser-473) following calcium-switching in NHU-
Con cell cultures, there was no such response in NHU-ECmut
cultures (Figure 4C). These findings account for the observed effect
of calcium-mediated contacts in regulating growth-promoting
pathways and provide direct evidence for E-cadherin-mediated
modulation of EGFR/ERK and PI3-K/AKT signalling.
Our observation of EGFR/ERK de-repression following E-
cadherin loss-of-function implies that elevated phospho-ERK
activity may account, at least in part, for the increased
proliferation rate of E-cadherin-disabled cells. However, the
ability of NHU-ECmut cells to display consistently higher growth
rates irrespective of extracellular calcium levels (Figure 4B) was
suggestive of potential involvement of additional signalling
pathways in driving cell proliferation. Another signalling candidate
for promoting an increased growth rate was b-catenin, as
immunofluorescence microscopy experiments revealed nuclear
b-catenin localisation both in NHU cells maintained in low
calcium (Figure 3B) and in NHU-ECmut cells maintained in
physiological calcium (Figure 3C). b-catenin is a multifunctional
protein that, upon activation, can act as a cofactor for the TCF/
LEF transcription factor complex to induce or enhance cell
proliferation [4]. We used a reporter assay to determine whether
nuclear b-catenin was active and able to trigger TCF transcrip-
tional activity in NHU-Con and NHU-ECmut cells. Like NHU
cells (not shown), NHU-Con cells showed some b-catenin/TCF
activity, which was diminished in the presence of physiological
calcium (Figure 4D). By contrast, NHU-ECmut cells showed high
levels of b-catenin/TCF activity, irrespective of the extracellular
calcium concentration (Figure 4D). Therefore, collectively, our
studies show that functional inactivation of E-cadherin in NHU
cells de-repressed EGFR/ERK signalling and enhanced b-
catenin/TCF transcriptional activity by several-fold.
Down-regulation of b-catenin by RNA interference
mimics E-cadherin engagement and influences PI3-K/AKT
activity and NHU cell proliferation
As shown above, whilst inducing PI3-K/AKT activity (Figure 2),
E-cadherin recruits b-catenin to the points of cell contact
(Figure 3B) and down-regulates b-catenin/TCF activity
(Figure 4D), whereas loss of E-cadherin function abolishes PI3-
K/AKT induction (Figure 4C) and confers constitutive activation
of b-catenin (Figure 4B). Collectively, these observations suggest
that E-cadherin-mediated sequestration of active b-catenin to the
cell surface coincides with induction of PI3-K/AKT activity. We
therefore next addressed the possibility that engineered loss of
active b-catenin may mimic the effects of E-cadherin engagement.
We produced NHU cell derivatives that were transduced with a
retrovirus expressing a b-catenin-specific short-hairpin RNA
(shRNA) adapted from a reported siRNA sequence [25].
Expression of active b-catenin was significantly decreased in b-
catenin shRNA-expressing (NHU-b-cat-KD) cells when compared
to control (NHU-Con) cells expressing control shRNA, as shown
by immunoblotting experiments (Figure 5A). The shRNA-
mediated b-catenin knock-down resulted in the induction of
phospho-AKT and this was accompanied by an almost three-fold
increase in E-cadherin expression (Figure 5A). This suggested that
forced down-regulation of active b-catenin allowed induction of
PI3-K/AKT activity. To confirm the functional involvement of
the induced phospho-AKT, we assessed population growth for
NHU-Con and NHU-b-cat-KD cell cultures in 0.09 mM or
2 mM calcium in the presence of the LY294002 inhibitor over a 6
day time-course (Figure 5B). As in NHU cells, the increased
proliferation rate characteristic of cultures grown in physiological
calcium was attenuated by LY294002 treatment in NHU-Con
cells, whereas the inhibitor had little effect on the exponential
growth rate in low calcium conditions. However, NHU-b-cat-KD
cell growth in physiological calcium was significantly reduced in
comparison to cultures of NHU-Con cells (Figure 5B), indicating
that b-catenin knock-down rendered NHU- b-cat-KD cells very
sensitive to the LY294002 inhibitor and confirming the impor-
tance of PI3-K/AKT signalling in conditions that mimic E-
cadherin engagement.
Discussion
Our study indicates a critical role for E-cadherin in monitoring
the ‘‘quality’’ of cell:cell interactions and regulating density-
dependent cell growth via the modulation of different growth
promoting pathways. Thus, E-cadherin has the capacity to
simultaneously regulate signalling through EGFR/ERK, PI3-K/
AKT and b-catenin/TCF pathways, with direct, context-specific
consequences for individual cell proliferation within a population.
In addition to demonstrating a central role for E-cadherin in
regulating epithelial tissue homeostasis and regeneration, it also
E-Cadherin Growth Regulation
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Figure 4. Loss of E-cadherin function enhances NHU cell proliferation and activates the EGFR/ERK and b-catenin/TCF signalling
pathways. (A) NHU-Con and NHU-ECmut cells were seeded in 96-well plates and cultured as above. [3H]-thymidine (TdR) precursor was added 24 hours
later and 16 hours post-pulsing, cells were harvested and TdR uptake measured by scintillation spectrometry. Data represent mean of cpm counts (6S.E.M.)
for 12 replicate wells. ns, non-significant; *, P,0.05; **, P,0.01. Of note, NHU-Con cells showed higher proliferation levels in low calcium compared to
physiologic calcium conditions, hence there was no apparent calcium-mediated enhancement in growth described above. This is because [3H]-thymidine
incorporation studies assessed proliferation in NHU cultures that were at .50% confluence, thus missing the initial phase where cells exhibit calcium-
mediated increased growth at low-density. (B) NHU-Con and NHU-ECmut cells were cultured in medium containing 0.09 mM (low Ca) or 2.0 mM (phys Ca)
[Ca2+] and proliferation assessed by cell counting as in Figure 1A. Each data point represents the mean (6S.E.M.) of 3 replicates and results are representative
of at least two independent experiments. Results for days 3, 5 and 7 are also presented in the form of bar graphs (lower panel) for the purpose of statistical
analysis and clarity. ns, non-significant; *, P,0.05; **, P,0.01; ***, P,0.001. (C) NHU-Con and NHU-ECmut cells were cultured in medium containing low
(-Ca2+) and physiological (+Ca2+) calcium levels for 24 hours and protein lysates were prepared. Expression of phospho-ERK (p-ERK) and -AKT (p-AKT) as well
as total ERK and AKT was determined using primary and secondary antibodies described in Figures 1C and 2A. Densitometry was performed to determine
fold induction of p-ERK and p-AKT expression following normalisation against total ERK and total AKT, respectively. Bar graphs represent results relative to
the expression level for NHU-Con in low calcium (-Ca2+). (D) NHU-Con and NHU-ECmut cells were transfected with the TCF/LEF firefly luciferase reporter
TOPflash or the FOPflash control plasmid, alongside the Renilla luciferase expression vector pRL-tk. Four hours post-transfection, culture supernatants were
adjusted for the desired level of calcium concentration, i.e. 0.09 mM (Low Ca2+) or 2.0 mM (Phys Ca2+). Cell lysates were prepared and reporter activity
assessed in a 96-well format using the Dual-Luciferase Reporter Assay on a microplate reader for pair-wise detection of luminescence activity for each
reporter. Firefly luciferase values were normalised against those of Renilla luciferase and were then expressed as fold activity with respect to that obtained for
FOPflash in NHU-Con cells cultured in low or physiological calcium. Bars represent mean fold Firefly luciferase activity (6S.E.M.) for 6 replicate samples.
doi:10.1371/journal.pone.0013621.g004
E-Cadherin Growth Regulation
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provides insight into the downstream sequelae of E-cadherin loss
in cancer.
The well-recognised property of E-cadherin as a metastasis
suppressor is generally attributed to its function in mediating
adherens junctions in the maintenance of tissue integrity. Although
it is also accepted that E-cadherin has a modulatory role in cell
proliferation and migration, its specific contribution has remained
more equivocal. One problem of interpretation is that reintro-
duction of E-cadherin expression into a malignant cell line tends to
reveal idiospecific effects, as it is unlikely to restore all normal
functions of E-cadherin against a background of multiple genetic/
epigenetic alterations. Pece and co-workers demonstrated E-
cadherin-dependent, ligand-independent activation of EGFR and
downstream MAPK pathways in the HaCaT cell line [7]. This
was consistent with E-cadherin providing a proliferation signal in
keratinocytes [8,26], or rescue from anoikis in squamous cell
Figure 5. Loss of b-catenin by shRNA-mediated knock-down mimics E-cadherin engagement. (A) NHU cells expressing b-catenin shRNA
(NHU-b-cat-KD) and their isogenic controls expressing scramble shRNA control (NHU-Con) were established by retrovirus transduction and the
efficiency of the shRNA to down-regulate b-catenin was assessed by immunoblotting. Lysates from NHU-Con and NHU-b-cat-KD cells maintained in
low calcium were probed for expression of active b-catenin (b-cat), E-cadherin (E-cad), phospho-AKT at S437 (p-AKT) and b-actin using mouse
antibodies (b-cat, E-cad and b-actin) and rabbit antiserum (p-AKT), followed by goat anti-mouse antibody conjugated with Alexa Fluor 680 or goat
anti-rabbit antibody conjugated with IRDye 800 as appropriate. Densitometry was performed to determine differences in protein expression with
respect to b-actin and fold differences following normalisation are indicated. (B) NHU-Con and NHU-b-cat-KD cell lines were seeded into 96-well
plates and cultured for a period of 6 days in medium containing either 0.09 mM (Low Ca) or 2.0 mM (Phys Ca) calcium concentration and in the
absence (Control) or presence of 5 mM of PI3-K inhibitor LY294002. Proliferation was determined on the basis of cell biomass using the MTT assay and
results are presented in upper and lower left panels. Data points represent mean absorbance values for 6 replicate wells (6S.E.M.). To allow easier
comparison between inhibitor-treated (+ LY) and non-treated cells, graphs for each cell line are also presented (upper and lower middle panels). In
addition, results for all data points are shown in the form of bar graphs (lower panel) for the purpose of statistical analysis. ns, non-significant;
*, P,0.05; **, P,0.01; ***, P,0.001.
doi:10.1371/journal.pone.0013621.g005
E-Cadherin Growth Regulation
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carcinoma [27]. However, in other cell types, such as mammary
epithelial cells [10,28,29], as well as melanoma and breast cancer
cell lines [11], E-cadherin-mediated cell-cell contacts have been
shown to suppress proliferation signals that are driven by RTKs,
particularly from the EGFR pathway. These contradictory
findings prompted us to study the precise influence of E-cadherin
on downstream growth-promoting cell signalling pathways in a
normal epithelial cell system.
At low density, NHU cells grown in physiological calcium
exhibited transiently-higher growth rates than cultures grown in
low calcium, which was attributable to activation of the PI3K/
AKT pathway. That this was the result of functional E-cadherin
cell contacts, rather than being attributable to the increase in
calcium alone, was indicated by the confinement of AKT
activation to juxtaposed NHU cells and the loss of the effect in
E-cadherin-null cultures. These observations are supported by the
findings of Liu and co-workers, who showed that E-cadherin-
mediated contacts were responsible for promoting proliferation in
mammary epithelial cells cultured at low densities [30], as well as a
study reporting that induction of cell proliferation by cell:cell
contacts in endothelial and smooth muscle cells was associated
with PI3K/AKT activation [31].
Our study was originally instigated on the basis of in vitro/in
virtuo comparison with an agent-based computational model of
epithelial cell interactions [17,18,19]. The most recent version of
the model incorporates a mathematical model of juxtacrine
EGFR/ERK activation to explore the importance of cell-cell
contact in regulating ERK activity and NHU cell proliferation
[20]. The modelling results predicted that transient cell contacts
occurring in low calcium conditions would result in rapid but
transient ERK activation. Simulated ‘‘virtual immunoblotting’’
data for a population of cells suggested that transient contacts
resulted in a high overall phospho-ERK signal. By comparison,
slowly-formed contacts stabilised by the formation of E-cadherin
junctions in physiological calcium conditions resulted in sustained
ERK activation, but the overall amount of phospho-ERK for the
total population was less than for cultures maintained in low
calcium concentrations [20]. The present experimental work
confirmed the model’s prediction that in physiological calcium
conditions, the amount of ERK phosphorylation for the
population is less than for an equivalent culture grown in low
calcium conditions. By extending our study to the AKT pathway,
we have also now provided an explanation for the increase in
proliferation rate observed previously in NHU cell cultures grown
in physiological calcium [17].
As E-cadherin contacts suppress EGFR/ERK signalling in
urothelial cells, the implication is that E-cadherin loss may directly
contribute to the activation of RTKs frequently reported in
carcinomas [32], including those of the bladder ([33] and
references therein). Engineering NHU cells with functionally-
inactivated E-cadherin enabled us to specifically probe the
importance of E-cadherin-associated cell contacts in cell prolifer-
ation. Expression of the dominant-negative H-2Kd-E-cad mutant
down-regulated endogenous E-cadherin by blocking its localisa-
tion to sites of cell-cell contact and abrogating the recruitment of
a-catenin and b-catenin. The H-2Kd-E-cad chimera interacted
with endogenous protein to recruit it to perinuclear, Golgi/late-
endosome compartments, reminiscent of the situation with normal
keratinocytes [22], but not immortalised HaCaT cells, where
surface localisation was reported [34]. Inactivation of E-cadherin
abolished calcium-mediated growth restraints, allowed de-repres-
sion of EGFR/ERK, diminished the influence of PI3-K/AKT in
NHU cell proliferation at low density and ‘‘released’’ b-catenin to
permit its re-localisation to the nucleus. The b-catenin knock-
down experiments revealed a mutually-exclusive relationship
between PI3-K and b-catenin signalling, as well as demonstrating
that active b-catenin has a repressor role on E-cadherin
expression. As a result of the loss of functional E-cadherin, the
de-repression of EGFR/ERK and constitutive activation of b-
catenin/TCF signalling (discussed below) allowed NHU cells to
resume their high proliferative potential even in physiological
calcium conditions.
Unlike previous studies that have suggested no constitutive
Wnt/b-catenin signalling in NHU cells [35], we believe that our
work provides the first evidence for an activated Wnt signalling
pathway in urothelial cells, as assessed by TCF/LEF reporter assay
in conditions where E-cadherin signalling was suppressed (low
calcium medium or expression of the H-2Kd-E-cad chimera).
Various reports give credence to a role for Wnt signalling in
bladder cancer, including epigenetic loss of Wnt inhibitory
components, such as WIF-1, DKK subunits and secreted
frizzled-related proteins (sFRP) [36,37], hypermethylation of the
APC locus [38] and loss of E-cadherin expression via CDH1 locus
hypermethylation or mutation [39]. This emergent evidence in
combination with our findings indicates that the down-regulation
of E-cadherin is permissive for Wnt signalling in urothelial cells.
It is well-established that E-cadherin plays a critical role in
epithelial carcinogenesis due to its importance in regulating cell-
cell adhesion [40]. E-cadherin expression is frequently lost in
aggressive epithelial cancers, including those of the bladder,
prostate, lung and pancreas [41]. In the case of bladder cancer,
loss of E-cadherin expression is a common event [42], which
occurs in advanced tumours as a result of CDH1 locus
hypermethylation or mutation [39] and there is evidence for a
strong association between hypermethylation of the E-cadherin
locus with high disease-progression risk [43]. Because restoration
of its expression often leads to growth-retardation, reduction of
invasive properties [44] and/or reversion of the tumour phenotype
from malignant to benign [45,46], E-cadherin has been generally
termed a metastasis suppressor [47]. Sensitivity to the EGFR
inhibitor, cetuximab, has been shown to require intact E-cadherin
expression and silencing of E-cadherin by RNA interference was
reported to reduce responsiveness to EGFR inhibition in
previously sensitive bladder cancer cell lines [48]. Although no
biological evidence was provided, the authors proposed that the
requirement for E-cadherin to achieve increased growth inhibition
by cetuximab might indicate a mechanism of E-cadherin-mediated
EGFR activation. We believe that our observation of E-cadherin-
mediated down-regulation of EGFR/ERK is not contradictory
and may provide a mechanistic explanation for these findings. Our
results imply that a reduced response to EGFR inhibitor by E-
cadherin-negative cells [48] may, at least in part, be due to high
amounts of EGFR-driven ERK activation resulting from loss of E-
cadherin function, thus reducing the efficacy of cetuximab
treatment. More importantly, loss of E-cadherin may result in
activation of additional growth-promoting signalling pathways
normally attenuated by E-cadherin-mediated contacts, such as
activation of Wnt and b-catenin/TCF signalling; such signals
would not be attenuated by cetuximab-mediated EGFR
inhibition.
In summary, following a functional inactivation approach our
studies provide, for the first time, molecular evidence that E-
cadherin engagement can dictate the activity of several mitogenic
signalling pathways, as it differentially regulates EGFR/ERK, PI3-
K/AKT and b-catenin/TCF. Studies using normal epithelial cell
cultures [49], including our own, clearly suggest that E-cadherin
loss-of-function may provide a growth advantage. This indicates
that its role in carcinogenesis is not limited to metastatic spread,
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but that impairment of E-cadherin may provide a growth
advantage at an earlier stage – such as in non-malignant, low-
grade papillary neoplasms of the bladder [50], early-stage
carcinomas of the cervix [51], or in tumours where E-cadherin
protein is expressed heterogeneously [50,52]. The understanding
of homeostatic regulation of normal epithelial tissue regeneration
could have profound implications for developing therapies to
target key growth promoting pathways.
Materials and Methods
Ethics Statement
NHU cell lines were established from urological specimens
obtained with written informed patient consent and approval from
the Leeds (East) and York NHS Research Ethics Committees.
Cell culture
NHU cell lines of finite lifespan were established and
maintained in keratinocyte serum-free medium containing bovine
pituitary extract, recombinant EGF and supplemented with
cholera toxin (KSFMc), using methods that have been described
in detail elsewhere [12,14]. NHU cells were used for retrovirus
transduction at passages 1 or 2 and subsequent experiments were
performed between passages 2-6. Retrovirus packaging PT67
fibroblasts (BD Biosciences, Oxford, UK) were maintained in DR
medium, consisting of a 1:1 (v:v) mixture of DMEM and RPMI
1640 (Invitrogen, Paisley, UK), containing 10% fetal bovine serum
(FBS, Harlan Sera-Lab, Loughborough, UK).
Preparation of retroviral vectors and retrovirus-producing
cell lines
The dominant-negative H-2Kd-E-cad mutant [26] was the gift
of Professor Fiona Watt (CRUK Research Institute, Cambridge,
UK). H-2Kd-E-cad cDNA was sub-cloned from pBabe-puro into
the XhoI site of the pLXSP retroviral plasmid [53]. Recombinant
vectors pLXSP-ECmut and pLXSP-ECrev were derived, contain-
ing the H-2Kd-E-cad fragment in the forward and reverse (non-
sense) orientations, respectively (pLXSP-ECrev was used as a
specificity control). For the preparation of short hairpin RNA
(shRNA) to target b-catenin, an siRNA previously reported [25]
was used and adapted for delivery using the pSIREN-RetroQ
retroviral vector system. Oligonucleotide primers were prepared
and cloned into pSIREN-RetroQ according to the manufacturer’s
instructions (Clontech, BD Biosciences), giving rise to vector pSIR-
b-cat. The pSIR-Con vector, which contained a scrambled
shRNA sequence, was used alongside as negative control.
Retroviral transduction of NHU cells
Retroviral transductions were performed as described previous-
ly [53,54]. PT67 fibroblasts were transfected with pLXSP-ECrev,
pLXSP-ECmut, pSIR-Con and pSIR-b-cat vectors using Effecte-
neTM (Qiagen, Crawley, UK). Stable retrovirus-producing lines
PT67-ECrev, PT67-ECmut, PT67-Con-sir and PT67-b-cat-sir
were established by selection in culture medium containing
4 mg/mL puromycin (Autogen Bioclear UK Ltd, Calne, UK).
Conditioned media from stable retrovirus producers were 0.45 mm
membrane-filtered, supplemented with 8 mg/mL polybrene (Sig-
maAldrich, Poole, UK) and used to infect NHU cell cultures for 5–
6 hours. The medium was replaced with KSFMc and two days
post-transduction, NHU cells were subjected to antibiotic selection
using 1.5 mg/mL puromycin. 2–3 independent NHU lines were
each transduced with PT67-ECrev, PT67-ECmut, pSIR-Con and
pSIR-b-cat virions resulting in the derivation of isogenic NHU-
Con and NHU-ECmut sub-lines as well as NHU-Con and NHU-
b-cat-KD sub-lines.
Cell proliferation assays
NHU cells and virally-transduced derivatives were cultured in
KSFMc containing low (0.09 mM) or physiological (2.0 mM) Ca2+
and proliferation was assessed by cell counting, by colorimetric
assay with thiazolyl blue tetrazolium (MTT; SigmaAldrich) and by
[3H]-thymidine incorporation. For counting, cells were seeded in
6-well plates at 26104 cells/well and counts performed for a
period of 9 days. For MTT assays, cells were seeded in 96-well
plates at 46103/well and proliferation was assessed over the
indicated time-course in the presence or absence of 5 mM
LY294002. Following treatment with MTT reagent (500 mg/mL)
(SigmaAldrich), absorbance at 570 nm was measured. For [3H]-
thymidine (TdR) incorporation [53], cells were seeded in 96-well
plates at 26104/well; TdR precursor (GE Healthcare, Bucks, UK)
was added 24 hours later at 0.5 mCi/well and 16 hours post-
pulsing, cells were harvested onto filter-mats and TdR uptake was
measured by scintillation spectrometry.
Flow cytometry
H-2Kd expression was analysed using a FITC-conjugated
antibody and an isotype control recommended by the manufac-
turer (BD Biosciences). Using previously described methods
[54,55], NHU cells were labelled with these antibodies and
analysed by flow cytometry on the FL-1 (FITC) channel. A
minimum of 10,000 cells were acquired on a CyAnTM instrument
and protein expression was analysed using SummitH software
(DakoCytomation, Ely, UK).
Immunoblotting
Cell lysates were prepared, resolved on NuPageH 4–12% bis-
Tris acrylamide gels in MES or MOPS running buffer (Invitrogen)
and transferred onto 0.45 mm PVDF membranes (GE Healthcare,
Bucks, UK) as previously [53,56]. Affinity-purified polyclonal
antibodies recognising EGFR (cat#2232), phospho-ERK
(cat#9101) and phospho-AKT S473 (cat#9271s) were from Cell
Signalling (Autogen Bioclear). Monoclonal antibodies against
total-ERK (clone#16) and total-AKT (clone#7) were from BD
Biosciences, b-actin (clone#AC-15) was from SigmaAldrich and
E-cadherin (mouse monoclonal clone #HECD-1) was from R&D
systems (Abingdon, UK). The 8E7 monoclonal antibody recog-
nising active, unphosphorylated b-catenin was a kind gift of Prof
Hans Clevers (Hubrecht Institute, UMC, Utrecht, Netherlands).
Membranes were probed with primary antibodies followed by goat
anti-rabbit immunoglobulins conjugated to IRDyeH 800 (Tebu-
bio, Peterborough, UK) or goat anti-mouse antibody conjugated
to Alexa FluorH 680 (Invitrogen). Immunolabelling was visualised
and densitometry performed using an Odyssey system (LiCor,
Cambridge, UK).
Immunofluorescence microscopy
NHU cell cultures were fixed with 10% formalin in PBS and
permeabilised in PBS containing 0.1% Triton-X and 10% goat
serum (SigmaAldrich). Antibodies used were: a- and b-catenin
(rabbit, cat#C-2081 and cat#C-2206, respectively; SigmaAl-
drich). Antibodies against H-2Kd, EGFR, E-cadherin, total/
phospho-ERK and total/phospho-AKT were as above. Following
labelling with primary antibody, cells were washed and incubated
with goat anti-mouse or anti-rabbit immunoglobulins conjugated
with either Alexa FluorH 488 or 594 (Invitrogen). Cell nuclei were
stained using 0.1 mg/mL Hoechst 33258 (SigmaAldrich). Labelled
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preparations were observed by epifluorescence on an Olympus
BX60 microscope.
Luciferase reporter assays
Cells were seeded in 24-well plates at 56104/well and
transfected as previously [54] using EffecteneTM with 0.5 mg of
either TOPflash (luciferase construct containing tandem repeats of
the minimal TCF promoter) or FOPflash (negative reporter
control construct that contains mutant TCF binding sites) plasmid
(Millipore, Watford, UK). Reporter plasmids were transfected
alongside 0.1 mg of Renilla luciferase expression vector pRL-tk as
a transfection control and for normalisation of luciferase activity.
Cell lysates were prepared and reporter activity assessed in a 96-
well format by the Dual-LuciferaseTM Reporter Assay according
to the manufacturer’s instructions (Promega, Southampton, UK)
on a POLARstar OPTIMA microplate reader (BMG Labtech,
Aylesbury, UK).
Statistics
Means and standard errors from the mean (S.E.M.) were used
as descriptive statistics. Unless otherwise stated, Student’s t-test
was used for evaluation of statistical significance.
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